LifeMD, Inc. (LFMD)Healthcare | Health Information Services | New York, United States | NasdaqGM
4.76 USD
+0.12
(2.586%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 4.69 -0.07 (-0.070%) ⇩ (July 13, 2026, 7:38 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:37 a.m. EDT
The investment case for LifeMD is currently fractured by severe operational execution issues. Despite a 'strong buy' analyst consensus driven by a low forward P/E and a massive 650% cumulative gain over the last nine years, the company is bleeding cash with negative free cash flow and a crushing -23.8% return on equity. The recent quarterly results confirm this distress: while revenue estimates were topped, the bottom line remains in the red with operating margins at -17.8%. This disconnect between the optimistic analyst narrative and the deteriorating financial reality creates a dangerous setup. The options market agrees with the pessimism, with traders loading up on cheap puts to hedge against further losses. Until the company demonstrates a path to profitability and stabilizes its burn rate, the stock remains a speculative trap where the 'value' metrics are likely masking fundamental rot. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.182504 |
| AutoTheta | 0.188995 |
| AutoETS | 0.191761 |
| AutoARIMA | 0.191816 |
| MSTL_70 | 0.214748 |
| MSTL_97 | 0.376720 |
| MSTL_70_97 | 0.398296 |
Forecast horizon: 60 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 0.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.479 |
| Excess Kurtosis | -0.32 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 41.052 |
| Revenue per Share | 4.186 |
| Market Cap | 230,205,568 |
| Forward P/E | 9.24 |
| Beta | 1.99 |
| Profit Margins | 2.93% |
| Previous Name | Conversion Labs, Inc. |
| Website | https://lifemd.com |
As of July 11, 2026, 6:37 a.m. EDT: Speculators are aggressively positioning for downside protection, evidenced by massive open interest in out-of-the-money puts (strikes 3.0 and 4.0) compared to negligible call volume. While there is some call activity at the 6.0 strike, the overwhelming volume imbalance in the put chain suggests a fear of further decline rather than a bullish breakout. Implied volatility is elevated on the downside strikes, indicating the market prices in significant risk of a drop.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.590106 |
| Address1 | 236 Fifth Avenue |
| Address2 | Suite 400 |
| All Time High | 33.02 |
| All Time Low | 0.15 |
| Ask | 5.83 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 1,133,070 |
| Average Daily Volume3 Month | 1,086,690 |
| Average Volume | 1,086,690 |
| Average Volume10Days | 1,133,070 |
| Beta | 1.986 |
| Bid | 3.52 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 0.316 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.76 |
| Current Ratio | 1.043 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 4.88 |
| Day Low | 4.54 |
| Debt To Equity | 41.052 |
| Display Name | LifeMD |
| Dividend Date | 1,602,633,600 |
| Earnings Call Timestamp End | 1,778,099,400 |
| Earnings Call Timestamp Start | 1,778,099,400 |
| Earnings Timestamp | 1,778,097,600 |
| Earnings Timestamp End | 1,785,960,000 |
| Earnings Timestamp Start | 1,785,960,000 |
| Ebitda | -14,298,176 |
| Ebitda Margins | -0.07396 |
| Enterprise To Ebitda | -14.121 |
| Enterprise To Revenue | 1.044 |
| Enterprise Value | 201,900,448 |
| Eps Current Year | 0.135 |
| Eps Forward | 0.515 |
| Eps Trailing Twelve Months | -0.44 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.6064 |
| Fifty Day Average Change | 0.15360022 |
| Fifty Day Average Change Percent | 0.033344958 |
| Fifty Two Week Change Percent | -59.0106 |
| Fifty Two Week High | 12.72 |
| Fifty Two Week High Change | -7.96 |
| Fifty Two Week High Change Percent | -0.6257861 |
| Fifty Two Week Low | 2.56 |
| Fifty Two Week Low Change | 2.2000003 |
| Fifty Two Week Low Change Percent | 0.8593751 |
| Fifty Two Week Range | 2.56 - 12.72 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,201,617,000,000 |
| Float Shares | 40,079,947 |
| Forward Eps | 0.515 |
| Forward P E | 9.242719 |
| Free Cashflow | -4,156,398 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 347 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.86807996 |
| Gross Profits | 167,826,416 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13912 |
| Held Percent Institutions | 0.40725 |
| Implied Shares Outstanding | 48,362,510 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,602,633,600 |
| Last Split Factor | 1:5 |
| Long Business Summary | LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. |
| Long Name | LifeMD, Inc. |
| Market | us_market |
| Market Cap | 230,205,568 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_688458 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -21,299,564 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 224,402,046 |
| Number Of Analyst Opinions | 8 |
| Open | 4.61 |
| Operating Cashflow | 8,098,111 |
| Operating Margins | -0.17799999 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 866 351 5907 |
| Post Market Change | -0.07000017 |
| Post Market Change Percent | -1.4705918 |
| Post Market Price | 4.69 |
| Post Market Time | 1,783,985,913 |
| Prev Name | Conversion Labs, Inc. |
| Previous Close | 4.64 |
| Price Eps Current Year | 35.25926 |
| Price Hint | 4 |
| Price To Book | 15.063292 |
| Price To Sales Trailing12 Months | 1.1907374 |
| Profit Margins | 0.0293 |
| Quick Ratio | 0.894 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.12 |
| Regular Market Change Percent | 2.58621 |
| Regular Market Day High | 4.88 |
| Regular Market Day Low | 4.54 |
| Regular Market Day Range | 4.54 - 4.88 |
| Regular Market Open | 4.61 |
| Regular Market Previous Close | 4.64 |
| Regular Market Price | 4.76 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 526,539 |
| Return On Assets | -0.13407 |
| Return On Equity | -2.38451 |
| Revenue Growth | -0.014 |
| Revenue Per Share | 4.186 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 48,362,510 |
| Shares Percent Shares Out | 0.13229999 |
| Shares Short | 6,397,957 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 5,587,448 |
| Short Name | LifeMD, Inc. |
| Short Percent Of Float | 0.1582 |
| Short Ratio | 6.31 |
| Source Interval | 15 |
| State | NY |
| Symbol | LFMD |
| Target High Price | 15.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 9.875 |
| Target Median Price | 10.0 |
| Total Cash | 34,478,136 |
| Total Cash Per Share | 0.713 |
| Total Debt | 6,172,897 |
| Total Revenue | 193,330,256 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.44 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.3355 |
| Two Hundred Day Average Change | 0.42450047 |
| Two Hundred Day Average Change Percent | 0.09791269 |
| Type Disp | Equity |
| Volume | 526,539 |
| Website | https://lifemd.com |
| Zip | 10,001 |